Rare Disease Week, the FDA, mortality in autism, trajectories and subcategories

This week’s podcast summarizes some highlights in scientific research and includes a recognition of Rare Disease Week and actions taken by the FDA to ease the criteria for evaluating genetic therapies for rare genetic disorders, the best study to date on the mortality in autism, genetic prediction of outcome in individuals with a diagnosis, and Uta Frith’s commentary on the concept of “spectrum”.

https://pubmed.ncbi.nlm.nih.gov/41773580

https://pubmed.ncbi.nlm.nih.gov/41651809

https://pubmed.ncbi.nlm.nih.gov/41661606

https://archive.ph/fPscR

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.